the strategies and processes to manage those risks;
the structure and organisation of the relevant risk management function or other appropriate arrangements;
the scope and nature of risk reporting and measurement systems; and
the policies for hedging and mitigating risk, and the strategies and processes for monitoring the continuing effectiveness of hedges and mitigants.
the name of the credit institution to which the requirements of this Directive apply;
an outline of the differences in the basis of consolidation for accounting and prudential purposes, with a brief description of the entities that are:
fully consolidated;
proportionally consolidated;
deducted from own funds; or
neither consolidated nor deducted;
any current or foreseen material practical or legal impediment to the prompt transfer of own funds or repayment of liabilities among the parent undertaking and its subsidiaries;
the aggregate amount by which the actual own funds are less than the required minimum in all subsidiaries not included in the consolidation, and the name or names of such subsidiaries; and
if applicable, the circumstance of making use of the provisions laid down in Articles 69 and 70.
summary information on the terms and conditions of the main features of all own funds items and components thereof;
the amount of the original own funds, with separate disclosure of all positive items and deductions;
the total amount of additional own funds, and own funds as defined in Chapter IV of Directive 2006/49/EC,
deductions from original and additional own funds pursuant to Article 66(2), with separate disclosure of items referred to in Article 57(q); and
total eligible own funds, net of deductions and limits laid down in Article 66.
a summary of the credit institution's approach to assessing the adequacy of its internal capital to support current and future activities;
for credit institutions calculating the risk‐weighted exposure amounts in accordance with Articles 78 to 83, 8 per cent of the risk‐weighted exposure amounts for each of the exposure classes specified in Article 79;
for credit institutions calculating risk‐weighted exposure amounts in accordance with Articles 84 to 89, 8 per cent of the risk‐weighted exposure amounts for each of the exposure classes specified in Article 86. For the retail exposure class, this requirement applies to each of the categories of exposures to which the different correlations in Annex VII, Part 1, points 10 to 13 correspond. For the equity exposure class, this requirement applies to:
each of the approaches provided in Annex VII, Part 1, points 17 to 26;
exchange traded exposures, private equity exposures in sufficiently diversified portfolios, and other exposures;
exposures subject to supervisory transition regarding capital requirements; and
exposures subject to grandfathering provisions regarding capital requirements;
minimum capital requirements calculated in accordance with Article 75, points (b) and (c); and
minimum capital requirements calculated in accordance with Articles 103 to 105, and disclosed separately.
a discussion of the methodology used to assign internal capital and credit limits for counterparty credit exposures;
a discussion of policies for securing collateral and establishing credit reserves;
a discussion of policies with respect to wrong-way risk exposures;
a discussion of the impact of the amount of collateral the credit institution would have to provide given a downgrade in its credit rating;
gross positive fair value of contracts, netting benefits, netted current credit exposure, collateral held and net derivatives credit exposure. Net derivatives credit exposure is the credit exposure on derivatives transactions after considering both the benefits from legally enforceable netting agreements and collateral arrangements;
measures for exposure value under the methods set out in Parts 3 to 6 of Annex III, whichever method is applicable;
the notional value of credit derivative hedges, and the distribution of current credit exposure by types of credit exposure;
credit derivative transactions (notional), segregated between use for the credit institution's own credit portfolio, as well as in its intermediation activities, including the distribution of the credit derivatives products used, broken down further by protection bought and sold within each product group; and
the estimate of α if the credit institution has received the approval of the competent authorities to estimate α.
the definitions for accounting purposes of ‘past due’ and ‘impaired’;
a description of the approaches and methods adopted for determining value adjustments and provisions;
the total amount of exposures after accounting offsets and without taking into account the effects of credit risk mitigation, and the average amount of the exposures over the period broken down by different types of exposure classes;
the geographic distribution of the exposures, broken down in significant areas by material exposure classes, and further detailed if appropriate;
the distribution of the exposures by industry or counterparty type, broken down by exposure classes, and further detailed if appropriate;
the residual maturity breakdown of all the exposures, broken down by exposure classes, and further detailed if appropriate;
by significant industry or counterparty type, the amount of:
impaired exposures and past due exposures, provided separately;
value adjustments and provisions; and
charges for value adjustments and provisions during the period;
the amount of the impaired exposures and past due exposures, provided separately, broken down by significant geographical areas including, if practical, the amounts of value adjustments and provisions related to each geographical area;
the reconciliation of changes in the value adjustments and provisions for impaired exposures, shown separately. The information shall comprise:
a description of the type of value adjustments and provisions;
the opening balances;
the amounts taken against the provisions during the period;
the amounts set aside or reversed for estimated probable losses on exposures during the period, any other adjustments including those determined by exchange rate differences, business combinations, acquisitions and disposals of subsidiaries, and transfers between provisions; and
the closing balances.
Value adjustments and recoveries recorded directly to the income statement shall be disclosed separately.
the names of the nominated ECAIs and ECAs and the reasons for any changes;
the exposure classes for which each ECAI or ECA is used;
a description of the process used to transfer the issuer and issue credit assessments onto items not included in the trading book;
the association of the external rating of each nominated ECAI or ECA with the credit quality steps prescribed in Annex VI, taking into account that this information needs not be disclosed if the credit institution complies with the standard association published by the competent authority; and
the exposure values and the exposure values after credit risk mitigation associated with each credit quality step prescribed in Annex VI, as well as those deducted from own funds.
for each sub-portfolio covered:
the characteristics of the models used;
a description of stress testing applied to the sub-portfolio;
a description of the approaches used for back-testing and validating the accuracy and consistency of the internal models and modelling processes;
the scope of acceptance by the competent authority; and
a description of the extent and methodologies for compliance with the requirements set out in Annex VII, Part B to Directive 2006/49/EC.
the approaches for the assessment of own funds requirements for operational risk that the credit institution qualifies for; and
a description of the methodology set out in Article 105, if used by the credit institution, including a discussion of relevant internal and external factors considered in the credit institution's measurement approach. In the case of partial use, the scope and coverage of the different methodologies used.
the differentiation between exposures based on their objectives, including for capital gains relationship and strategic reasons, and an overview of the accounting techniques and valuation methodologies used, including key assumptions and practices affecting valuation and any significant changes in these practices;
the balance sheet value, the fair value and, for those exchange-traded, a comparison to the market price where it is materially different from the fair value;
the types, nature and amounts of exchange-traded exposures, private equity exposures in sufficiently diversified portfolios, and other exposures;
the cumulative realised gains or losses arising from sales and liquidations in the period; and
the total unrealised gains or losses, the total latent revaluation gains or losses, and any of these amounts included in the original or additional own funds.
the nature of the interest rate risk and the key assumptions (including assumptions regarding loan prepayments and behaviour of non-maturity deposits), and frequency of measurement of the interest rate risk; and
the variation in earnings, economic value or other relevant measure used by the management for upward and downward rate shocks according to management's method for measuring the interest rate risk, broken down by currency.
a description of the credit institution's objectives in relation to securitisation activity;
the roles played by the credit institution in the securitisation process;
an indication of the extent of the credit institution's involvement in each of them;
the approaches to calculating risk weighted exposure amounts that the credit institution follows for its securitisation activities;
a summary of the credit institution's accounting policies for securitisation activities, including:
whether the transactions are treated as sales or financings;
the recognition of gains on sales;
the key assumptions for valuing retained interests; and
the treatment of synthetic securitisations if this is not covered by other accounting policies;
the names of the ECAIs used for securitisations and the types of exposure for which each agency is used;
the total outstanding amount of exposures securitised by the credit institution and subject to the securitisation framework (broken down into traditional and synthetic), by exposure type;
for exposures securitised by the credit institution and subject to the securitisation framework, a breakdown by exposure type of the amount of impaired and past due exposures securitised, and the losses recognised by the credit institution during the period;
the aggregate amount of securitisation positions retained or purchased, broken down by exposure type;
the aggregate amount of securitisation positions retained or purchased, broken down into a meaningful number of risk weight bands. Positions that have been risk weighted at 1 250 % or deducted shall be disclosed separately;
the aggregate outstanding amount of securitised revolving exposures segregated by the originator's interest and the investors' interest; and
a summary of the securitisation activity in the period, including the amount of exposures securitised (by exposure type), and recognised gain or loss on sale by exposure type.